Source: Reuters

JSB Partners: BRIEF-Matinas Biopharma retains JSB Partners to pursue strategic options for MAT9001

* Matinas Biopharma retains JSB Partners to pursue strategic options for MAT9001

Read full article »
JSB Partners's Competitors | JSB Partners's News | JSB Partners's Financials
Stay up-to-date with the latest news on JSB Partners
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Wolfgang Stoiber's photo - Managing Partner of JSB Partners

Managing Partner

Wolfgang Stoiber

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on JSB Partners